News & Updates

Show Multimedia Only
Hydroxychloroquine protects SLE patients against CV events Hydroxychloroquine protects SLE patients against CV events

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024

Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.

11 Sep 2024